Does INFLIXIMAB-DYYB Cause C-reactive protein increased? 431 Reports in FDA Database

Q: Does INFLIXIMAB-DYYB cause C-reactive protein increased?

431 reports of C-reactive protein increased have been filed with the FDA for INFLIXIMAB-DYYB, representing 1.7% of all INFLIXIMAB-DYYB adverse event reports.

Q: How dangerous is C-reactive protein increased from INFLIXIMAB-DYYB?

Of 431 reports, 5 (1.2%) resulted in death and 164 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 431 reports of C-reactive protein increased have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 1.7% of all adverse event reports for INFLIXIMAB-DYYB.

431

Reports of C-reactive protein increased with INFLIXIMAB-DYYB

1.7%

of all INFLIXIMAB-DYYB reports

Deaths

164

Hospitalizations

How Dangerous Is C-reactive protein increased From INFLIXIMAB-DYYB?

Of the 431 reports, 5 (1.2%) resulted in death, 164 (38.1%) required hospitalization, and 12 (2.8%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 431 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Condition aggravated (10,275) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Drug ineffective (3,112) Fatigue (3,111) Weight increased (2,848) Malaise (2,766) Weight decreased (2,703)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which INFLIXIMAB-DYYB Alternatives Have Lower C-reactive protein increased Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

INFLIXIMAB-DYYB Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased INFLIXIMAB-DYYB Demographics